• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12G filed by Catalent Inc.

    12/30/24 8:00:08 AM ET
    $CTLT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CTLT alert in real time by email
    15-12G 1 d644126d1512g.htm 15-12G 15-12G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 15

     

     

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

    UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

    OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Commission File Number 001-36587

     

     

    Catalent, Inc.

    (Exact name of registrant as specified in its charter)

     

     

    14 Schoolhouse Road, Somerset, New Jersey 08873

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

    Common Stock, $0.01 par value per share

    (Title of each class of securities covered by this Form)

    None

    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

    Rule 12g-4(a)(1)

      ☒

    Rule 12g-4(a)(2)

      ☐

    Rule 12h-3(b)(1)(i)

      ☒

    Rule 12h-3(b)(1)(ii)

      ☐

    Rule 15d-6

      ☐

    Rule 15d-22(b)

      ☐

    Approximate number of holders of record as of the certification or notice date: One (1).

     

     

     


    On December 18, 2024, Catalent, Inc., a Delaware corporation (“Catalent”), Creek Parent, Inc., a Delaware corporation (“Parent”), and Creek Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), completed the transactions contemplated by that certain Agreement and Plan of Merger, dated as of February 5, 2024 (the “Merger Agreement”), by and among Catalent, Parent and Merger Sub. Pursuant to the Merger Agreement, Merger Sub merged with and into Catalent, with Catalent surviving such merger as a wholly owned subsidiary of Parent.

    Pursuant to the requirements of the Securities Exchange Act of 1934, Catalent, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

     

        CATALENT, INC.
    Date: December 30, 2024     By:  

    /s/ JOSEPH A. FERRARO

          Joseph A. Ferraro
          Senior Vice President, General Counsel, Chief Compliance Officer & Secretary
    Get the next $CTLT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTLT

    DatePrice TargetRatingAnalyst
    11/16/2023$45.00 → $53.00Neutral → Outperform
    Robert W. Baird
    9/5/2023$62.00Hold → Buy
    Argus
    7/20/2023$43.00Equal Weight
    Wells Fargo
    7/5/2023$45.00Neutral
    JP Morgan
    6/14/2023$45.00 → $44.00Buy → Hold
    Jefferies
    5/22/2023$90.00 → $45.00Overweight → Neutral
    JP Morgan
    5/15/2023$55.00 → $29.00Buy → Hold
    Deutsche Bank
    5/8/2023$28.00Neutral → Underperform
    BofA Securities
    More analyst ratings